Hot Stocks: FreeSeas Inc.(NASDAQ:FREE), Alvarion Ltd (USA)(NASDAQ:ALVR), Sequenom Eltek Ltd.(NASDAQ:ELTK), Hemispherx BioPharma, Inc(NYSEMKT:HEB)

Submitted By on August 21, 2013 - 11:36 PM

Las Vegas, NV – Aug 21 2013 — (TechSonian) – Value Penny Stocks issues a special report on FreeSeas Inc.(NASDAQ:FREE), Alvarion Ltd (USA)(NASDAQ:ALVR), Sequenom Eltek Ltd.(NASDAQ:ELTK), Hemispherx BioPharma, Inc(NYSEMKT:HEB).

FreeSeas Inc.(NASDAQ:FREE) shares lost 4.86% to $0.200. FreeSeas Inc. (FreeSeas) is a parent holding company of its ship-owning companies. The Company owns nine vessels, each of which is owned through a separate wholly owned subsidiary. Its fleet consists of five Handysize vessels and two Handymax vessels that carry a variety of drybulk commodities, including iron ore, grain and coal, which are referred to as major bulks, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar and rice, or minor bulks.

Is FREE A Strong Buy? Get Advantage Of Our Free Trend Analysis Here

Alvarion Ltd (USA)(NASDAQ:ALVR) shares decreased 24.14% to $0.880. Alvarion Ltd. is engaged in the design, development, manufacturing and marketing of wireless products. The Company focuses on two line of business: the carriers line of business, which includes operators, broadband service providers, competitive local exchange carriers and regional carriers, and the enterprise line of business, which includes government authorities, municipalities, and wireless Internet service providers with integrated end-to-end networks and solutions based on the worldwide interoperability for microwave access standard, as well as other wireless broadband solutions. Solutions for carriers include providing subscribers with home, office and personal broadband connectivity for Internet access, social networking, gaming, voice over Internet protocol, video and other bandwidth-intensive applications.

Should Investors Rush To Buy ALVR After The Solid Rally? Get Special Report Here

Eltek Ltd.(NASDAQ:ELTK) shares added 5.78% to $1.30. Eltek Ltd. manufactures and supplies technologically advanced, custom made circuitry solutions for use in compact electronic products. The Company provides specialized services and is a solution provider in the PCB business, mainly in Israel, Europe and North America.

How Should Investors Trade ELTK After The Recent Volatility? Get Free Report Here

Hemispherx BioPharma, Inc(NYSEMKT:HEB) stock gained 2.54% to $0.242. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Hemispherx focuses on two core pharmaceutical technology platforms Ampligen and Alferon N Injection.The commercial focus for Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as an influenza vaccine enhancer (adjuvant) for both therapeutic and preventative vaccine development.

How Should Investors Trade HEB After The Recent Volatility? Get Free Report Here

About Us:

Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.


We at are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.

Please Read Our Full Disclaimer at: